Sunday, 17 March | 1300–1800
Monday, 18 March | 0730–1830
Tuesday, 19 March | 0700–1700
Monday, 18 March | 1015–1815
Tuesday, 19 March | 1000–1515
Explore the exhibitor directory and schedule meetings, plus make sure to take advantage of the opportunities to connect with colleagues in the exhibit hall during the networking breaks.
Attend the Interactive Regulatory Panel to be part of an open discussion on global issues relevant to the aseptic industry and FDA.
Make the most of your professional development by attending in-depth training in 4 critical areas of pharma manufacturing, taking place 20–22 March.
We welcome your feedback throughout the year on ISPE's continuing education events. A survey will be emailed to all attendees at the close of the conference. Thank you for providing your feedback and ideas for future topics.
Follow the official hashtag of the 2019 ISPE Aseptic Conference #ISPEAseptic to stay up to date on what is going on throughout the conference, and use it to share your own experiences on social media.
In the pharmaceutical industry, which is highly regulated, aseptic processing is a critical component that ensures the sterility of products. Regulators have a set of comprehensive requirements that minimize the risk of contamination. Regulators set the requirements; however, the industry has an obligation to the patients who rely on and expect a drug that is safe and free of contamination....
Like any investment in digital manufacturing systems, demonstrating business payback before and after investment is critical to getting MES projects approved and verifying profitability after investment. Whether it is introducing MES, expanding it to additional sites, switching software, upgrading existing software, or developing electronic production records (EPR) for new drug products,...
Sustainability is emerging as a pivotal force influencing the pharmaceutical industry’s dynamics and steering companies towards transformative change. The focus of this analysis is to delve into the sustainability key performance indicators (KPIs) of prominent pharmaceutical players, namely Pfizer, Sanofi, Glaxo Smith Kline (GSK), Becton Dickinson, Johnson & Johnson, Abbott, Eli Lilly, and...